Sungkyunkwan University · 医学
Professor Ju-Hong Min's research lab specializes in neuroimmunology and neurodegenerative diseases, with a primary focus on neuromyelitis optica spectrum disorder (NMOSD), amyotrophic lateral sclerosis (ALS), and related central nervous system (CNS) inflammatory and degenerative conditions. The lab investigates the pathophysiology, clinical phenotypes, and neuroimaging correlates of NMOSD, particularly brain involvement, cognitive dysfunction, and white matter network alterations using advanced MRI techniques such as diffusion tensor imaging and graph theory. Additionally, the lab explores symptom burden, including fatigue and quality of life, and evaluates novel therapeutic interventions, such as ursodeoxycholic acid in ALS, emphasizing patient-centered outcomes and treatment safety.
Figures are computed from collected data and may differ slightly.
We report the case of a patient who developed extensive brain lesions during fingolimod (FTY720) treatment in the TRANSFORMS study. His initial diagnosis was multiple sclerosis, but after encephalopathy anti-aquaporin4 antibody (anti-AQP4 Ab) was detected, it was changed to neuromyelitis optica spectrum disorder. After treatment with fingolimod, he developed bilateral extensive brain lesions. The brain MRI showed lesions predominantly involving the right frontal and parietal lobes, with vasogeni
Age of onset could be an important predictor of lesion location and clinical course of patients with NMOSD.
To evaluate the efficacy and safety of ursodeoxycholic acid (UDCA) with oral solubilized formula in amyotrophic lateral sclerosis (ALS) patients, patients with probable or definite ALS were randomized to receive oral solubilized UDCA (3.5 g/140 mL/day) or placebo for 3 months after a run-in period of 1 month and switched to receive the other treatment for 3 months after a wash-out period of 1 month. The primary outcome was the rate of progression, assessed by the Appel ALS rating scale (AALSRS),
Fatigue is a prevalent symptom and major burden in neuroimmunological diseases. In neuromyelitis optica spectrum disorder (NMOSD), a severe autoimmune central nervous system (CNS) inflammatory disease with autoantibodies reactive to aquaporin-4, there are few reports about fatigue and quality of life (QOL). We aimed to evaluate the severity of fatigue and its relationship with QOL in patients with NMOSD. We prospectively studied patients with NMOSD who were in remission and seropositive for anti
<b>Background:</b> In neuromyelitis optica spectrum disorder (NMOSD), brain involvement is common and cognitive dysfunction is frequently found. The study investigated alterations of white matter (WM) connectivity using graph theory and correlations with cognitive dysfunction in patients with NMOSD. <b>Methods:</b> We prospectively enrolled patients with NMOSD (<i>N</i> = 14) and age- and sex-matched healthy controls (<i>N</i> = 21). Structural connections between any pair of the 90 cortical and
The implications for clinical settings and the suggestions for future research are discussed.
The risk of dementia increased in MS and NMOSD patients and dementia risk was higher in MS than in NMOSD.
UA levels are associated with clinical disease status in patients with NMO. Further investigations are recommended to elucidate the role of UA as a biomarker of disease activity in NMO.
Background People with multiple sclerosis (MS) are more likely to develop stroke than those without. However, little is known about the association between neuromyelitis optica spectrum disorder (NMOSD) and the risk of stroke. We aimed to estimate the risk of stroke in patients with MS and NMOSD in South Korea. Methods Data from the Korean National Health Insurance between January 2010 and December 2017 were analysed. A total of 1541/1687 adult patients with MS/NMOSD, who were free of stroke wer
The most common diagnoses with elevated CSF-ADA levels were HM, followed by TBM and VM. Clinicians should carefully consider the differential diagnoses in patients with elevated CSF-ADA levels, especially those in the early stage of meningitis without microbiological evidence for TBM.
Open papers in the app to read, cite, and organize with AI.
